US2016243030A1PendingUtilityA1

Aqueous Ophthalmic Composition

34
Assignee: ROHTO PHARMAPriority: Dec 4, 2012Filed: May 5, 2016Published: Aug 25, 2016
Est. expiryDec 4, 2032(~6.4 yrs left)· nominal 20-yr term from priority
Inventors:Ryo KomurasakiYoko MizutareAtsuko Nakata
A61P 27/02A61K 47/44A01N 37/36A61K 47/10A61K 31/23C11D 1/74C11D 3/24C11D 3/382A01N 25/22A61K 9/0048A61K 47/14A61K 9/08C11D 3/2037A61K 47/34C11D 3/48C11D 1/825A61K 31/07C11D 1/721
34
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to an aqueous ophthalmic composition comprising (A) polyoxyethylene castor oil, (B) polyethylene glycol monostearate, and (C) at least one member selected from the group consisting of sesame oil, castor oil, vitamin A, and chlorobutanol.

Claims

exact text as granted — not AI-modified
1 - 7 . (canceled) 
     
     
         8 . An aqueous ophthalmic composition, comprising (A) polyoxyethylene castor oil, (B) polyethylene glycol monostearate, and (C) at least one member selected from the group consisting of sesame oil, castor oil, vitamin A, and chlorobutanol. 
     
     
         9 . The aqueous ophthalmic composition according to  claim 8 , further comprising (D) a buffer. 
     
     
         10 . The aqueous ophthalmic composition according to  claim 8 , further comprising (E) a surfactant other than components (A) and (B). 
     
     
         11 . The aqueous ophthalmic composition according to  claim 8 , wherein the aqueous ophthalmic composition is eye drops, an eye wash, a solution for wearing a contact lens, or a contact lens care solution. 
     
     
         12 . The aqueous ophthalmic composition according to  claim 9 , further comprising (E) a surfactant other than components (A) and (B). 
     
     
         13 . The aqueous ophthalmic composition according to  claim 9 , wherein the aqueous ophthalmic composition is eye drops, an eye wash, a solution for wearing a contact lens, or a contact lens care solution. 
     
     
         14 . The aqueous ophthalmic composition according to  claim 12 , wherein the aqueous ophthalmic composition is eye drops, an eye wash, a solution for wearing a contact lens, or a contact lens care solution. 
     
     
         15 . The aqueous ophthalmic composition according to  claim 8 , wherein total content of component (C) Is 0.00002 to 10,000 parts by weight based on 1 part by weight of total content of component (A). 
     
     
         16 . The aqueous ophthalmic composition according to  claim 8 , wherein total content of component (C) is 0.00002 to 10,000 parts by weight based on 1 part by weight of total content of component (B). 
     
     
         17 . The aqueous ophthalmic composition according to  claim 10 , wherein total content of component (C) is 0.00002 to 10,000 parts by weight based on 1 part by weight of total content of component (A). 
     
     
         18 . The aqueous ophthalmic composition according to  claim 10 , wherein total content of component (C) is 0.00002 to 10,000 parts by weight based on 1 part by weight of total content of component (B).

Join the waitlist — get patent alerts

Track US2016243030A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.